管理亚临床心房的当代实践
Buthainah Alhwarat1, Omar Darwish1, Sai Nikhila Ghanta2
1Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Journal of clinical medicine
|August 14, 2025
概括
由心脏器件检测到的亚临床心房动 (SCAF) 需要个性化的口服抗凝药决定. 平衡中风风险和出血潜力是管理这些无症状心律不整的关键.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 医疗器械 医疗器械
背景情况:
- 在心脏植入式电子设备 (CIED) 的患者中,亚临床心房动 (SCAF) 是常见的.
- SCAF发作可能会先于临床心房动,并增加血栓栓塞事件的风险.
- 对SCAF的管理策略,特别是口服抗凝剂 (OAC) 的使用,尚未确立,并且仍然存在争议.
研究的目的:
- 审查关于SCAF管理的当前文献和临床研究.
- 为指导关于SCAF抗凝治疗的决策.
- 确定治疗选择,以限制SCAF患者的并发症.
主要方法:
- 使用Medline,Scopus,Google Scholar和Embase数据库进行全面的文献审查.
- 对SCAF和心房高频发作 (AHREs) 相关的当前文献和临床研究的分析.
- 专注于指导抗凝血和限制并发症策略的证据.
主要成果:
- 对于SCAF/AHREs的OAC启动的决定应该是个性化的.
- 风险效益评估平衡中风风险与出血潜力至关重要.
- 受益于OAC的最佳患者亚组需要进一步澄清.
结论:
- 在SCAF/AHREs中OAC决策中,个性化评估至关重要.
- 需要进行持续的研究,以完善SCAF的治疗指南.
- 未来的研究将澄清哪些患者亚组从抗凝治疗中获益最多.
相关概念视频
Dysrhythmias VI: Management of Dysrhythmias
107
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
107
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
164
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
164
Mitral Regurgitation III: Medical Management
30
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Aortic Regurgitation III: Medical Management
43
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
43
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21


